Showing 41-50 of 58 grants

Title Institution Researcher Program Duration Total Award Amount
Transcriptional memory in human islet organogenesis Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) Eiji Yoshihara Cures 01-April-2022 to 31-March-2027 $749,995.50
Creation of a Commercializable Multi-Omics Resource from T1D Patient-Derived iPSC-Derived 3D Islet Organoid Models Greenstone Biosciences, Inc. Angelos Oikonomopoulos Cures 25-June-2026 to 24-June-2029 $1,200,000.00
ENCRT-hPI (Immune-Protected ENCRT Extension Study), Evaluation of an immune-protected ENCRT-101 loaded with primary human islets in adults with Type 1 Diabetes, with and without standard-of-care portal vein islet infusion. Encellin Crystal Nyitray Cures 25-June-2026 to 24-June-2028 $2,500,000.00
Broad Scope CMC, Non-Clinical, and Regulatory Support Dark Horse Consulting Nathan Manley Cures 01-September-2025 to 31-December-2026 $85,000.00
IND Readiness Gap Analysis and Risk Assessment Dark Horse Consulting Amanda Mack Cures 15-June-2026 to 30-November-2026 $80,325.05
Engineering and Translational Control of Vascularization for Durable Islet Replacement Therapies Cedars-Sinai Medical Center Dhruv Sareen Cures 01-October-2026 to 30-September-2029 $899,998.80
Scalable GMP-Compliant Manufacturing of iPSC-Derived Insulin-Producing Cells: From Seed Train to Cryopreserved Product Cedars-Sinai Medical Center Dhruv Sareen Cures 01-April-2026 to 31-March-2028 $600,000.00
Cellular Sentinels of Islet Transplant Rejection California Institute of Technology Mikhail Shapiro Cures 01-July-2023 to 30-June-2027 $750,000.00
Clinical Trial of Denosumab for Type 1 Diabetes Beckman Research Institute of the City of Hope Rupangi Vasavada Cures 01-October-2023 to 30-November-2027 $2,232,400.00
Do Islet Somatic Mutations Contribute to T1D Age at Onset? Beckman Research Institute of the City of Hope Melanie Shapiro Cures 01-March-2026 to 28-February-2027 $100,000.00